GNRH1 and leiomyoma: On the other hand, there is evidence that long-term progestogen administration reduces the occurrence of fibroids [106,107,108], and MPA administration prevented any significant re-growth following the treatment of women with symptomatic fibroids with the short-acting Gn-RH superagonist analog Buserelin [109].